A carregar...
First experience with BAK-free travoprost 0.004% in topical glaucoma medication
OBJECTIVES: Benzalkonium chloride (BAK)-free travoprost 0.004% (Travatan Z(®), Alcon Laboratories, Inc, Fort Worth, TX) is a new formulation that was developed with the aim of creating a formulation of travoprost that would maintain the intraocular pressure (IOP)-lowering efficacy and have an improv...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3259093/ https://ncbi.nlm.nih.gov/pubmed/22259229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S24983 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|